68Ga- and 211At-Labeled RGD Peptides for Radiotheranostics with Multiradionuclides-Reference-Cited by-同舟云学术

68Ga- and 211At-Labeled RGD Peptides for Radiotheranostics with Multiradionuclides

Published:2021-08-17 Issue:9 Volume:18 Page:3553-3562
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Ogawa Kazuma¹²^ORCID,Echigo Hiroaki²,Mishiro Kenji¹^ORCID,Hirata Saki²,Washiyama Kohshin³^ORCID,Kitamura Yoji⁴,Takahashi Kazuhiro³,Shiba Kazuhiro⁴,Kinuya Seigo⁵

Affiliation:

1. Institute for Frontier Science Initiative, Kanazawa University, Kanazawa 920-1192, Japan

2. Graduate School of Medical Sciences, Kanazawa University, Kanazawa 920-1192, Japan

3. Advanced Clinical Research Center, Fukushima Global Medical Science Center, Fukushima Medical University, 1 Hikarigaoka, Fukushima 960-1295, Japan

4. Research Center for Experimental Modeling of Human Disease, Kanazawa University, Takara-machi 13-1, Kanazawa, Ishikawa 920-8640, Japan

5. Department of Nuclear Medicine, Kanazawa University Hospital, Kanazawa University, Takara-machi 13-1, Kanazawa, Ishikawa 920-8641, Japan

Funder

Mitani Foundation for Research and Development

Pancreas Research Foundation of Japan

Program of the Network-type Joint Usage/Research Center for Radiation Disaster Medical Science

Kanazawa University SAKIGAKE project 2020

Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.1c00460

Reference29 articles.

1. Theranostics: Combining Imaging and Therapy

2. Radiotheranostics: a roadmap for future development

3. Radiotheranostics with radiolanthanides: Design, development strategies, and medical applications

4. Development of Diagnostic and Therapeutic Probes with Controlled Pharmacokinetics for Use in Radiotheranostics

5. Radiotheranostics in Cancer Diagnosis and Management

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of the Precision-designed Radiopharmaceuticals Depending on the Targeting Molecules;RADIOISOTOPES;2024-07-15

2. In vivo stable 211At-labeled prostate-specific membrane antigen-targeted tracer using a neopentyl glycol structure;EJNMMI Radiopharmacy and Chemistry;2024-06-17

3. Optimizing the pharmacokinetics of an 211At-labeled RGD peptide with an albumin-binding moiety via the administration of an albumin-binding inhibitor;European Journal of Nuclear Medicine and Molecular Imaging;2024-04-04

4. Recent advances in the development of 225Ac- and 211At-labeled radioligands for radiotheranostics;Analytical Sciences;2024-04-02

5. Synthesis of closo- and nido-carborane derivatives of the KRGD peptide;Journal of Organometallic Chemistry;2024-03